23486 PHASE
A Distributed Pharmaceutical Applications Server
Keywords: High-Performance Computing and Networking
Technical - Metacomputing, Parallel computing, Simulation, Internet
Uses - Molecular modeling
Industrial Applications - Drug design, biotechnology research
The PHASE project aims at providing a central access point to powerful computing platforms running applications used in the pharmaceutical drug discovery process (e.g. MaxHom, Genequiz, Dragon and Msap). By linking WAN connected HPCN systems running these applications, a service is provided to industrial users who need high performance computing power for their specific tasks in drug design projects, but find the cost to be prohibitive, or have not decided yet to invest in the acquisition and management of the software and platforms.
Building on previous projects, and on a national metacomputing initiative, PHASE combines important paralel bio-informatics applications for collaborative use in a distributed server environment.
Based on the results and experiences gained in these projects, PHASE has the potential to demonstrate the feasibility and cost-effectiveness of HPCN in industrial key-applications in the field of pharmaceutical drug design, and in biotechnology research.
Moreover the project intends to demonstrate that this type of service, accessible also through Internet, may be extended to other application codes, and other industrial sectors.
|
Contact Point | |
| Mrs Anke Weber | tel +49.5251.60.6331 |
| University Paderborn | fax +49.5251.60.6297 |
| Paderborn Centre of Parallel Computing | email: weber@uni-paderborn.de |
| Fürstenallee 11 | http://www.uni-paderborn.de/pc2/projects/phase |
| D-33102 Paderborn |
|
|
Participants |
Country |
Role |
|
PC² |
D |
C |
|
Merck |
D |
P |
|
Novo |
DK |
P |
|
EBI |
UK |
P |
|
MRC-NIMR |
UK |
P |
|
OML |
UK |
A |
|
Start Date |
Duration |
|
February 1997 |
24 months |
This page is located at /esprit/src/23486.htm
It was last updated on 18 November 1998, and is maintained by